Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States

References

• Agency for Toxic Substance & Disease Registry. 2014. Asbestos toxicity: Who is at risk of exposure to asbestos? Atlanta, GA: Agency for Toxic Substance & Disease Registry, Centers for Disease Control and Prevention. August.
   Google Scholar
• Albin, M., K. Jakobsson, R. Atteweell, L. Johansson, and H. Welinder. 1990. Mortality and cancer morbidity in cohorts of asbestos cement workers and referents. British Journal of Industrial Medicine 47:602–10.
   PubMedGoogle Scholar
• Anderson, H. A., R. Lilis, S. M. Daum, A. S. Fischbein, and I. J. Selikoff. 1976. Household –contact asbestos neoplastic risk. In Occupational carcinogenesis, ed. U. Saffiotti and J. K. Wagoner, Annals of the New York Academy of Sciences 271: 311–23.
   Google Scholar
• Ascoli, V., D. Cavone, E. Merler, P. G. Barbieri, L. Romeo, F. Nardi, and M. Musti. 2007. Mesothelioma in blood related subjects: Report of 11 clusters among 1954 Italy cases and review of the literature. American Journal of Industrial Medicine 50:357–69. doi:10.1002/(ISSN)1097-0274.
   PubMed Web of Science ®Google Scholar
• Ascoli, V., C. Mecucci, and S. Knuutila. 2001. Genetic susceptibility and familial malignant mesothelioma-Correspondence. Lancet 357:1804. doi:10.1016/S0140-6736(00)04922-9.
   PubMed Web of Science ®Google Scholar
• Ascoli, V., E. Romeo, C. Carnovale Scalzo, I. Cozzi, L. Ancona, F. Cavariani, A. Balestri, L. Gasperini, and F. Forastiere. 2014. Familial malignant mesothelioma: A population-based study in central Italy (1980–2012). Cancer Epidemiology 38:273–78. doi:10.1016/j.canep.2014.02.014.
   PubMed Web of Science ®Google Scholar
• Aust, A. E., P. M. Cook, and R. F. Dodson. 2011. Morphological and chemical mechanisms of elongated mineral particle toxicities. Journal of Toxicology and Environmental Health, Part B 14:40–75. doi:10.1080/10937404.2011.556046.
   PubMed Web of Science ®Google Scholar
• Barbieri, P. G., M. Migliori, and E. Merier. 1999. Incidence of malignant mesothelioma and occupational asbestos exposure in Northern Italy. La Medicina del Lavoro 90:762–75.
   PubMedGoogle Scholar
• Baris, I., M. Artvinli, A. Sahin, T. Savas, and M. L. Erkan. 1979. Study of malignant pleural mesothelioma, chronic fibrotic pleurisy and pleural plaques related to the environment in Turkey. Revues des Malades Respiratoroires 7:687–94.
   Google Scholar
• Battifora, H., and W. T. E. McCaughey. 1995. Tumours of the serosal membranes. In Atlas of tumour pathology, third series, fascicle, 15. Washington, DC: Universities Associated for Research & Education in Pathology, Inc,, Armed Forces Institute Pathology.
   Google Scholar
• Betti, M., E. Casalone, D. Ferrante, A. Romanelli, F. Grosso, S. Guarrera, L. Righi, S. Vatrano, G. Pelosi, R. Libener, D. Mirabelli, R. Boldorini, C. Casadio, M. Papotti, G. Matullo, C. Magnani, and I. Dianzan. 2015. Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area. Genes, Chromosomes and Cancer 54:51–62. doi:10.1002/gcc.v54.1.
   PubMed Web of Science ®Google Scholar
• Bignon J, Y. Iwatsubo, F. Galateau-Salle, and A. J. Valleron. 2002. History and experience of mesothelioma in Europe. In Mesothelioma, ed. B. W.S. Robinson and A. P. Chahinian, 29–53. London, UK: Martin Dunitz Ltd., Taylor & Francis Group.
   Google Scholar
• Bregni M, S. Siena, G. Bonadonna. 2000. Principi di Proliferazione cellular. In Medicina oncologica, ed. G. Bonadonna, G. Robustelli, and M. della Cuna, 73–115. Milano, Italy: Masson [in Italian].
   Google Scholar
• Brody, A. R. 2010. Editorial asbestos and lung disease. American Journal of Respiratory Cell and Molecular Biology 42:131–32. doi:10.1165/rcmb.2010-2002ED.
   PubMed Web of Science ®Google Scholar
• Camus, M., J. Siematycki, and G. Meek. 1998. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. New England Journal of Medicine 338:1565–71. doi:10.1056/NEJM199805283382201.
   PubMed Web of Science ®Google Scholar
• Carbone, M., I. Baris, P. Bertino, B. Brass, S. Comertpay, A. U. Dogan, G. Gaudino, S. Jube, S. Kanodia, C. R. Partridge, H. I. Pass, A. S. Rivera, I. Steele, M. Tuncer, S. Way, H. Yang, and A. Miller. 2011. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proceedings of the National Academy of Sciences 108:13618–23. doi:10.1073/pnas.1105887108.
   PubMed Web of Science ®Google Scholar
• Carbone, M., S. Emri, A. U. Dogan, I. Steele, M. Tuncer, H. I. Pass, and Y. I. Baris. 2007. A mesothelioma epidemic in cappadocia: Scientific developments and unexpected social outcomes. Nature Reviews, Cancer 7:147–54. doi:10.1038/nrc2068.
   PubMed Web of Science ®Google Scholar
• CDC. 2014. Compressed mortality file 1999–2013 on CDC WONDER Online Database for Mesothelioma (C45: ICD-10). Centers for Disease Control and Prevention, National Center for Health Statistics. October 30. Compressed Mortality File 1999-2013 Series 20, No. 25. http://wonder.cde.gov/cmf-icd10.html.
   Google Scholar
• Checkoway, H., N. E. Pearce, and D. J. Crawford-Brown. 1989. Research methods in occupational epidemiology. New York, NY: Oxford University Press.
   Google Scholar
• Cheung, M., Y. Kadaniya, J. Talarchek, J. Pei, J. A. Ohar, O. R. Kayalah, and J. R. Testa. 2016. Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene–environment interaction. Cancer Letters. 76:206–15.
   PubMed Web of Science ®Google Scholar
• Cheung, M., Y. Kadariya, J. Pei, J. Talarchek, F. Facciolo, P. Visca, L. Righi, I. Cozzi, J. R. Testa, and V. Ascoli. 2015. An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation. Cancer Genetics 208:502–7. doi:10.1016/j.cancergen.2015.07.004.
   PubMed Web of Science ®Google Scholar
• Chiappino, G. 2005. Mesothelioma: Il ruolo delle fibre ultrafine e conseguenti riflessi in campo preventive e mediclo legale. La Medicina del Lavoro 96:3–23 [in Italian].
   PubMedGoogle Scholar
• Churg, A., and F. H. Y. Green. 1998. Pathology of occupational lung disease, 2nd ed. Baltimore, MD: Williams & Wilkins.
   Google Scholar
• Collegium Ramazzini. 2015a. Comments on the causation of malignant mesothelioma: Rebutting the false concept that recent exposures to asbestos do not contribute to causation of mesothelioma. Carpi, Italy. http://www.collegiumramazzini.org/download/18_EighteenthCRStatement ( accessed October 14, 2015).
   Google Scholar
• Collegium Ramazzini. 2015b. The global health dimensions of asbestos and asbestos-related diseases. Collegium Ramazzini, Carpi, Italy, http://www.collegiumramazzini.org/download/18_EighteenthCRStatement ( accessed October 14).
   Google Scholar
• Collins, V. P., R. K. Loeffler, and H. Tivey. 1956. Observations on growth rates of human tumours. American Journal of Roentgenology, Radiolum Therapy, and Nuclear Medicine 76:988.
   PubMed Web of Science ®Google Scholar
• Cotran, R. S., V. Kumar, and T. Collins. 1999. Neoplasia. In Robbins pathologic basis of disease, ed. R. S. Cortran, V. Kumar, and S. L. Robbins, 300–1. Philadelphia, PA: W. B. Saunders.
   Google Scholar
• CR (Consensus Report). 1997. Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Scandinavian Journal of Work, Environment & Health 23:311–16.
   PubMed Web of Science ®Google Scholar
• Crovella, S., A. M. Bianco, J. Vuch, L. Zupin, R. R. Moura, E. Trevisan, M. Schneider, A. Brollo, E. M. Nicastro, A. Coszeni, G. Zabucchi, and V. Borelli. 2016. Iron signature in asbestos-induced malignant pleural mesothelioma: A population-based autopsy study. Journal of Toxicology and Environmental Health, Part A 79:129–41. doi:10.1080/15287394.2015.1123452.
   PubMed Web of Science ®Google Scholar
• Cyphert, J. M., D. J. Carlin, A. Nysak, M. C. Schladweiler, A. D. Ledbetter, J. H. Shannahan, U. P. Kodavanti, and S. H. Gavett. 2015. Comparative long-term toxicity of Libby amphibole and amosite asbestos in rats after single or multiple intratracheal exposures. Journal of Toxicology and Environmental Health, Part A 78:151–65. doi:10.1080/15287394.2014.947455.
   PubMed Web of Science ®Google Scholar
• Delgermaa, V., K. Takahashi, E.-K. Park, G. V. Le, H. Toshiyuki, and T. Sorahan. 2011. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bulletin of the World Health Organization 89:716C–724C. doi:10.2471/BLT.11.086678.
   PubMed Web of Science ®Google Scholar
• Dodson, R. F. 2011. Analysis and relevance of asbestos burden in tissue. In Asbestos risk assessment, epidemiology, and health effects, ed. R. F. Dodson and S. P. Hammar, 49–108. 2nd ed. Bacon Raton, FL: CRC Press, Taylor & Francis Group.
   Google Scholar
• Dragon, J., J. Thompson, M. MacPherson, and A. Shukla. 2015. Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure. Journal of Cellular Biochemistry 116:1540–52. doi:10.1002/jcb.v116.8.
   PubMed Web of Science ®Google Scholar
• Driscoll, T., D. I. Nelson, K. Steenland, J. Leigh, M. Concha-Barrientos, M. Fingerhut, and A. Prűss- Ustűn. 2005. The global burden of disease due to occupational carcinogens. American Journal of Industrial Medicine 48:419–31. doi:10.1002/(ISSN)1097-0274.
   PubMed Web of Science ®Google Scholar
• Flora, S., and A. Vannucci. 1996. La prevenzione primaria dei tumori. Professione: Sanitá Pubblica e Medicina Pratica. Roma, Italy.
   Google Scholar
• Galateau-Sallé, F., ed. 2006. Pathology of malignant mesothelioma. international mesothelioma panel. London, UK: Springer –Verlag.
   Google Scholar
• Global Burden of Disease. 2015a. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 1888 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:743–800. doi:10.1016/S0140-6736(15)60692-4.
   PubMed Web of Science ®Google Scholar
• Governa, M., M. Amati, S. Fontana, I. Visona, G. C. Botta, F. Mollo, D. Bellis, and P. Bo. 1999. Role of iron in asbestos-body-induced oxidant radical generation. Journal of Toxicology and Environmental Health. Part A 58:279–87. doi:10.1080/009841099157241.
   PubMed Web of Science ®Google Scholar
• Health Effects Institute. 1991. Asbestos in public and commercial buildings: A literature review and synthesis of current knowledge. Cambridge, MA: Health Effects Institute—Asbestos Research.
   Google Scholar
• Henderson, D. W., K. B. Shilkin, and S. L. P. Langlois, Whitaker, D. 1992. Malignant mesothelioma. New York, NY: Hemisphere.
   Google Scholar
• Henley, S. J., T. C. Larson, M. Wu, C. S. A. Vinicius, M. Lewis, G. A. Pinheiro, and C. Eheman. 2013. Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008. International Journal of Occupational and Environmental Health 19:1–10. doi:10.1179/2049396712Y.0000000016.
   PubMed Web of Science ®Google Scholar
• Hillerdal, G. 1999. Mesothelioma: Cases associated with non-occupational and low dose exposures. Occupational and Environmental Medicine 56:505–13. doi:10.1136/oem.56.8.505.
   PubMed Web of Science ®Google Scholar
• Hodgson, J. T., D. M. Elvenny, A. J. Darnton, M. J. Price, and J. Peto. 2005. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. British Journal of Cancer 92:587–93.
   PubMed Web of Science ®Google Scholar
• IARC. 1987. Erionite. In Silica and some silicates, IARC monogr. Eval. Carcinogen. Risk Chem. Hum. 42:225–39.
   Google Scholar
• IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 2012. A review of human carcinogens, part C: Arsenic, metals, fibres, and dusts, vol. 100. Lyon, France: Published by the International Agency for Research on Cancer, World Health Organization.
   Google Scholar
• Institute of Medicine. 2006. Asbestos: Selected cancers. Washington, DC: Institute of Medicine of the National Academies, The National Academies Press.
   Google Scholar
• International Programme on Chemical Safety. 1998. Environmental Health Criteria 203—Chrysotile asbestos. International Programme on Chemical Safety, United Nations Environment Programme, The International Labour Organisation, and the World Health Organization, Geneva; WHO. Occupational Exposure limit for asbestos, WHO/OCH/89. I. Office of Occupational Health. Geneva, Switzerland: World Health Organization.
   Google Scholar
• International Programme on Chemical Safety. 2016. Asbestos. http://www.who.int/ipcs/assessment /public _health/asbestos/en/.
   Google Scholar
• Iwatsubo, Y., J. C. Pairon, C. Boutin, O. Menard, N. Massin, D. Caillaud, E. Orlowald, F. Galateau-Sallé, J. Bignon, and P. Brochard. 1998. Pleural mesothelioma: Dose-response relation at low levels of asbestos exposure in a French population-based case-control study. American Journal of Epidemiology 148:133–42. doi:10.1093/oxfordjournals.aje.a009616.
   PubMed Web of Science ®Google Scholar
• Jaurand, M. C. 1996. Use of in-vitro genotoxicity and cell transformation assays to evaluate the potential carcinogenicity of fibres. IARC SciIOM Publication 55–72, PMID-9101317, Lyon, France.
   Google Scholar
• Jones, R. D., D. M. Smith, and P. G. Thomas. 1988. Mesothelioma in Great Britain in 1968–1983. Scandinavian Journal of Work, Environment & Health 14:145–52. doi:10.5271/sjweh.1938.
   PubMed Web of Science ®Google Scholar
• Klebe, S., and D. W. Henderson. 2011. The molecular pathogenesis of asbestos-related disorders. In Asbestos risk assessment, epidemiology, and health effects, 2nd ed., ed. R. F. Dodson and S. P. Hammar, 109–30. Bacon Raton, FL: CRC Press, Taylor & Francis Group.
   Google Scholar
• Krupoves, A., M. Camus, and L. De Guire. 2015. Incidence of malignant mesothelioma of the pleura in Québec and Canada from 1984 to 2007, and projections from 2008 to 2032. American Journal of Industrial Medicine 58:473–82. doi:10.1002/ajim.22442.
   PubMed Web of Science ®Google Scholar
• La Vecchia, C., and P. Boffetta. 2011. Role of stopping exposure and recent exposure to asbestos in the risk of mesothelioma. European Journal of Cancer Prevention 21:227–30. doi:10.1097/CEJ.0b013e32834dbc56.
   Web of Science ®Google Scholar
• Langer, A. M., and R. P. Nolan. 1989. Fibre type and burden in parenchymal tissues of workers occupationally exposed to asbestos in the United States. In Non-occupational exposures to mineral fibres, ed. J. Bignon, J. Peto, and R. Saracci, 330–35. IARC Sci. Pub. no. 90. Lyon, France: International Agency for Research on Cancer, World Health Organization.
   Google Scholar
• Larson, T., N. Melnikova, S. I. Davis, and P. Jamison. 2007. Incidence and descriptive epidemiology of mesothelioma in the United States, 1999-2002. International Journal of Occupational and Environmental Health 13:398–403. doi:10.1179/oeh.2007.13.4.398.
   PubMed Web of Science ®Google Scholar
• Leigh, J., P. Davidson, L. Hendrie, and D. Berry. 2002. Malignant mesothelioma in Australia 1945-2000. Annals of Occupational Hygiene 46 (Suppl. 1):160–65. doi:10.1093/annhyg/46.suppl_1.160.
   Google Scholar
• Lemen, R. 2014. Epidemic to pandemic: Asbestos in our world. In International day of asbestos victims—State of science—State of the world, 3–33. Marc Hindry, Paris, France: Andeva, Association Nationale de Défense des Victimes de l’Amiante.
   Google Scholar
• Lemen, R. A. 2011. Epidemiology of asbestos-related diseases and the knowledge that led to what is known today. In Asbestos risk assessment, epidemiology, and health effects, ed. R. F. Dodson and S. P. Hammar, 132–267. 2nd ed. Bacon Raton, FL: (CRC Press, Taylor & Francis Group.
   Google Scholar
• Lemen, R. A., and R. F. Dodson. 2012. Asbestos. In Patty’s toxicology, 6th ed., ed. E. Bingham and B. Cohrssen, vol. 5, chap. 83. Hoboken, NJ: John Wiley & Sons, Inc.
   Google Scholar
• Lin, R. T., K. Takahashi, A. Karjalainen, T. Hoshuyama, D. Wilson, and T. Kameda. 2007. Ecological association between asbestos-related diseases and historical asbestos consumption: An international analysis. Lancet 369:844–49. doi:10.1016/S0140-6736(07)60412-7.
   PubMed Web of Science ®Google Scholar
• Linton, A., J. Vardy, S. Clarke, and N. Van Zandwijk. 2012. The ticking time-bomb of asbestos: Its insidious role in the development of malignant mesothelioma. Critical Reviews in Oncology/Hematology 84:200–12. doi:10.1016/j.critrevonc.2012.03.001.
   PubMed Web of Science ®Google Scholar
• Lunder, S. 2015. Asbestos nation. Washington, DC: Environmental Working Group.
   Google Scholar
• Magnani, C., C. Bianchi, E. Chellini, D. Consonni, B. Fubini, V. Gennaro, A. Marinaccio, M. Menegozzo, D. Mirabelli, E. Merler, F. Merletti, M. Musti, E. Oddone, A. Romanelli, B. Terracini, A. Zona, C. Zocchetti, M. Alessi, A. Baldassarre, I. Dianzani, M. Maule, C. Mensi, and S. Silvestri. 2015. III Italian consensus conference on malignant mesothelioma of the pleura. Epidemiology, public health and occupational medicine related issues. La Medicina del Lavoro 106:325–32.
   PubMed Web of Science ®Google Scholar
• Magnani, C., B. Fubini, D. Mirabelli, C. Bianchi, E. Chellini, V. Gennaro, A. Marinaccio, M. Menegozzo, E. Merler, F. Merletti, M. Musti, E. Pira, A. Romanelli, B. Terracini, and A. Zona. 2013. Pleural mesothelioma: Epidemiological and public health issues. Report from the second Italian consensus conference on pleural mesothelioma. La Medicina del Lavoro 104:191–202.
   PubMed Web of Science ®Google Scholar
• Marinaccio, A., A. Binazzi, M. Bonafede, M. Corfiati, D. Di Marzio, A. Scarselli, M. Verardo, D. Mirabelli, V. Gennaro, C. Mensi, G. Schallemberg, E. Merler, C. Negro, A. Romanelli, E. Chellini, S. Silvestri, M. Cocchioni, C. Pascucci, F. Stracci, V. Ascoli, L. Trafficante, I. Angelillo, M. Musti, D. Cavone, G. Cauzillo, F. Tallarigo, R. Tumino, and M. Melis; ReNaM Working Group. 2015. Malignant mesothelioma due to non-occupational asbestos exposure from the Italian national survelliance system (ReNaM): Epidemiology and public health issues. Occupational and Environmental Medicine 72:648–55. doi:10.1136/oemed-2014-102297.
   PubMed Web of Science ®Google Scholar
• Mark, E. J., and T. Yokoi. 1991. Absence of evidence for a significant background incidence of diffuse malignant mesothelioma apart from asbestos exposure. Annals of the New York Academy of Sciences 643:196–204. doi:10.1111/nyas.1991.643.issue-1.
   PubMed Web of Science ®Google Scholar
• Markowitz, S. 2015. Asbestos-related lung cancer and malignant mesothelioma of the pleura: Selected current issues. Seminars in Respiratory and Critical Care Medicine 36:334–46. doi:10.1055/s-00000075.
   PubMed Web of Science ®Google Scholar
• Maudsley, G., and E. M. I. Williams. 1996. Inaccuracy in death certification—Where are we now? Journal of Public Health 18:59–66. doi:10.1093/oxfordjournals.pubmed.a024463.
   Web of Science ®Google Scholar
• McDonald, A. D. 1980. Malignant mesothelioma in Quebec. In Biological effects of mineral fibres, 673–80. IARC Scientific Publication No. 30. J.D. Wagner, Lyon, France: International Agency for Research on Cancer.
   Google Scholar
• McDonald, J. C., and A. D. McDonald. 1996. The epidemiology of mesothelioma in historical context. European Respiratory Journal 9:1932–42. doi:10.1183/09031936.96.09091932.
   PubMed Web of Science ®Google Scholar
• Metintas, M., G. Hillerdal, and S. Metintas. 1999. Malignant mesothelioma due to environmental exposure to erionite: Follow-up of a Turkish emigrant cohort. European Respiratory Journal 13:523–26. doi:10.1183/09031936.99.13352399.
   PubMed Web of Science ®Google Scholar
• Mullan, R. J., and L. I. Murthy. 1991. Occupational sentinel health events: An up- dated list for physicians recognition and public health surveillance. American Journal of Industrial Medicine 19:775–79. doi:10.1002/(ISSN)1097-0274.
   PubMed Web of Science ®Google Scholar
• National Institute for Occupational Safety and Health. 1976. Revised recommended asbestos standard. Cincinnati, Ohio: U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health.
   Google Scholar
• National Institute for Occupational Safety and Health. 1995. Report to congress on workers’ home contamination study conducted under The Workers’ Family Protection Act (29 U.S.C. 671a). Cincinnati, Ohio: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health.
   Google Scholar
• Neumann, V., A. Rütten, M. Scharmach, K.-M. Müller, and M. Fischer. 2004. Factors influencing long-term survival in mesothelioma patients – Results of the German mesothelioma register. International Archives of Occupational and Environmental Health 77:191–99. doi:10.1007/s00420-003-0498-6.
   PubMed Web of Science ®Google Scholar
• Newhouse, M., J. Sanchis, and J. Bienenstock. 1976a. Lung defense mechanisms (first of two parts). New England Journal of Medicine 295:990–98. doi:10.1056/NEJM197610282951805.
   PubMed Web of Science ®Google Scholar
• Newhouse, M., J. Sanchis, and J. Bienenstock. 1976b. Lung defense mechanisms (second of two parts). New England Journal of Medicine 295:1045–52. doi:10.1056/NEJM197611042951905.
   PubMed Web of Science ®Google Scholar
• Newhouse, M. L., and G. Berry. 1976. Predictions of mortality from mesothelial tumours in asbestos factory workers. British Journal of Industrial Medicine 33:147–51.
   PubMedGoogle Scholar
• Newhouse, M. L., and G. Berry. 1979. Patterns of mortality in asbestos factory workers in London. Annals of the New York Academy of Sciences 330:53–60. doi:10.1111/nyas.1979.330.issue-1.
   PubMedGoogle Scholar
• Newhouse, M. L., G. Berry, and J. C. Wagner. 1985. Mortality of factory workers in east London 1933-80. British Journal of Industrial Medicine 42:4–11.
   PubMedGoogle Scholar
• Newhouse, M. L., and H. Thompson. 1965. Mesothlioma of pleura and peritoneum following exposure to asbestos in the London area. British Journal of Industrial Medicine 22:261–69.
   PubMedGoogle Scholar
• Nicholson, W. J. 2001. The carcinogenicity of chrysotile asbestos-A review. Industrial Health 39:57–64. doi:10.2486/indhealth.39.57.
   PubMed Web of Science ®Google Scholar
• Nishikawa, K., K. Takahashi, A. Karjalainen, C.-P. Wen, S. Furuya, T. Hoshuyama, M. Todoroki, Y. Kiyomoto, D. Wilson, T. Higashi, M. Ohtaki, G. Pan, and G. Wagner. 2008. Recent mortality from pleural mesothelioma, historical patterns of asbestos use and adoption of bans: A global assessment. Environmental Health Perspectives 116:1675–80. doi:10.1289/ehp.11272.
   PubMed Web of Science ®Google Scholar
• Panou, V., M. Vyberg, U. M. Weinreich, C. Meristoudis, U. G. Falkmer, and O. D. Røe. 2015. The established and future biomarkers of malignant pleural mesothelioma. Cancer Treatment Reviews 41:486–95. doi:10.1016/j.ctrv.2015.05.001.
   PubMed Web of Science ®Google Scholar
• Pascolo, L., A. Gianoncelli, G. Schneider, M. Salomé, M. Schneider, C. Calligaro, M. Kiskinova, M. Melato, and C. Rizzardi. 2013. The interaction of asbestos and iron in lung tissue revealed by synchrotron-based scanning x-ray microscopy. Scientific Reports 3:1123.
   PubMed Web of Science ®Google Scholar
• Pass, H. I., N. Vogelzang, S. Hahn, and M. Carbone. 2004. Malignant pleural mesothelioma. Current Problems in Cancer 28:93–174. doi:10.1016/j.currproblcancer.2004.04.001.
   PubMed Web of Science ®Google Scholar
• Peto, J. 1978. The hygiene standard for chrysotile asbestos. Lancet 311:484–89. doi:10.1016/S0140-6736(78)90145-9.
   Google Scholar
• Peto, J., C. Rake, C. Gilham, and J. Hatch. 2009. Occupational, domestic and environmental mesothelioma risks in Britain: A case-control study. Prepared by the Institute of Cancer Research and the London School of Hygiene and Tropical Medicine for the Health and Safety Executive, Health and Safety Executive, London, UK.
   Google Scholar
• Peto, J., H. Seidman, and I. J. Selikoff. 1982. Mesothelioma mortality in asbestos workers: Implications for models of carcinogenesis and risk assessment. British Journal of Cancer 45:124–35. doi:10.1038/bjc.1982.15.
   PubMed Web of Science ®Google Scholar
• Pinherio, G. A., V. C. S. Antao, K. M. Bang, and M. D. Attfield. 2004. Malignant mesothelioma surveillance: A comparison of ICD 10 mortality data with SEER incidence data in nine areas of the United States. International Journal of Occupational and Environmental Health 10:251–55. doi:10.1179/oeh.2004.10.3.251.
   PubMed Web of Science ®Google Scholar
• Pinton, G., E. Brunelli, B. Murer, R. Puntoni, M. Puntoni, D. A. Fennell, G. Gaudino, L. Mutti, and L. Moro. 2009. Estrogen receptor-beta affects the prognosis of human malignant mesothelioma. Cancer Research 69:4598–604. doi:10.1158/0008-5472.CAN-08-4523.
   PubMed Web of Science ®Google Scholar
• Pira, E., C. Pelucchi, L. Buffoni, A. Palmas, M. Turbiglio, E. Negri, P. G. Piolatto, and C. La Vecchia. 2005. Cancer mortality in a cohort of asbestos textile workers. British Journal of Cancer 92:580–86. doi:10.1038/sj.bjc.6602240.
   PubMed Web of Science ®Google Scholar
• Raffn, E., E. Lynge, K. Juel, and B. Korsgaard. 1989. Incidence of cancer and mortality among employees in the asbestos cement industry in Denmark. British Journal of Industrial Medicine 46:90–96.
   PubMedGoogle Scholar
• Reid, A., N. H. De Klerk, C. Magnani, D. Ferrante, G. Berry, A. W. Musk, and E. Merier. 2014. Mesothelioma risk after 40 years since first exposure to asbestos: A pooled analysis. Thorax 69:107–12. doi:10.1136/thoraxjnl-2013-204161.
   PubMed Web of Science ®Google Scholar
• Ries, L. A. G., B. A. Miller, B. F. Hankey, C. Kosary, A. Harras, and B. Edwards, eds. 1994. SEER cancer statistics review, 1973–1991, Tables and graphs. Bethesda, MD: National Cancer Institute. (NIH Publication no 94-2789).
   Google Scholar
• Robinson, B. W., A. W. Musk, and R. A. Lake. 2005. Malignant mesothelioma. The Lancet 366:397–408. doi:10.1016/S0140-6736(05)67025-0.
   PubMed Web of Science ®Google Scholar
• Robinson, B. W. S., and A. P. Chahinian, eds. 2002. Mesothelioma. London, UK: Martin Dunitz Ltd., Taylor & Francis Group.
   Google Scholar
• Rödelsperger, K., J. K-H, H. Pohlabeln, W. Römer, and H. J. Woitowitz. 2001. Asbestos and man-made vitreous fibers as risk factors for diffuse malignant mesothelioma: Results from a German hospital-based case-control study. American Journal of Industrial Medicine 39:262–75. doi:10.1002/1097-0274(200103)39:3<262::AID-AJIM1014>3.0.CO;2-R.
   PubMed Web of Science ®Google Scholar
• Röesler, J. A., H. J. Woitowitz, H.-J. Lange, R. H. Woitowitz, K. Ulm, and K. Rödelsperger. 1994. Mortality rates in a female cohort following asbestos exposure in Germany. Journal of Occupational Medicine 36:889–93.
   PubMedGoogle Scholar
• Rothman, K. J., and S. Greenland. 2005. Causation and causal inference in epidemiology. American Journal of Public Health 95 (Supp 1):S144–S150. doi:10.2105/AJPH.2004.059204.
   Google Scholar
• Roushdy-Hammody, I., J. Siegel, S. Emri, J. R. Testa, and M. Carbone. 2001. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 357:444–45. doi:10.1016/S0140-6736(00)04013-7.
   PubMed Web of Science ®Google Scholar
• Rudd, R., J. Moore-Gillon, and M. Muers. 2002. Mesothelioma, letter to the editor. Thorax 57:187. doi:10.1136/thorax.57.2.187.
   PubMed Web of Science ®Google Scholar
• Rusch, A., G. Ziltener, K. Nackaerts, W. Weder, S. Ra, and E. Felley-Bosco. 2015. Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases. Lung Cancer 87:77–79. doi:10.1016/j.lungcan.2014.10.017.
   PubMed Web of Science ®Google Scholar
• Seaton, A. 2002. One fibre or many; what causes mesothelioma, letter to the editor. Thorax 57:186–87. doi:10.1136/thorax.57.2.186-b.
   PubMed Web of Science ®Google Scholar
• Sekido, Y. 2008. Molecular biology of malignant mesothelioma. Environmental Health and Preventive Medicine 13:65–70. doi:10.1007/s12199-007-0015-8.
   PubMedGoogle Scholar
• Selikoff, I. J., and D. H. K. Lee. 1978. Asbestos and disease. New York, NY: Academic Press.
   Google Scholar
• Sneddon, S., J. S. Leon, I. M. Dick, G. Cadby, N. Olsen, F. Brims, R. J. Allcock, E. K. Moses, P. E. Melton, N. De Klerk, A. W. Musk, B. W. Robinson, and J. Creaney. 2015. Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma. Gene 563:103–05. doi:10.1016/j.gene.2015.03.031.
   PubMed Web of Science ®Google Scholar
• Sporn T. A., V. L. Roggli. 2004. Mesothelioma. In Pathology of asbestos-associated diseases, 2nd ed., ed. V. l. Roggli, T. D. Oury, and T. A. Sporn, 104–168. New York, NY Springer.
   Google Scholar
• Stayner, L. T., D. A. Dankovic, and R. A. Lemen. 1996. Occupational exposure to chrysotile asbestos and cancer risk: A review of the amphibole hypothesis. American Journal of Public Health 86:197–186. doi:10.2105/AJPH.86.2.179.
   Web of Science ®Google Scholar
• Steenland, K., C. Burnet, N. Lalich, E. Ward, and J. Hurrell. 2003. Dying for work: The magnitude of US mortality from selected causes of death associated with occupation. American Journal of Industrial Medicine 43:461–82. doi:10.1002/(ISSN)1097-0274.
   PubMed Web of Science ®Google Scholar
• Szeszenia-Dabrowska, N., U. Wilczynska, W. Szymczak, and A. Strzelecka. 2002. Mortality study of workers compensated for asbestosis in Poland, 1970–1997. International Journal of Occupational Medicine and Environmental Health 15:267–78.
   PubMedGoogle Scholar
• Tannock, I. F. 1983. Biology and tumor growth. Hospital Practice 18:91–93. doi:10.1080/21548331.1983.11702514.
   Web of Science ®Google Scholar
• Terracini, B., D. Mirabelli, C. Magnani, D. Ferrante, F. Barone-Adesi, and M. Bertolotti. 2014. A critique to a review on the relationship between asbestos exposure and the risk of mesothelioma. Letter to the editor. European Journal of Cancer Prevention 23:492–94. doi:10.1097/CEJ.0000000000000057.
   PubMed Web of Science ®Google Scholar
• Testa, J. R., M. Cheung, J. Pei, J. E. Below, Y. Tan, E. Sementino, N. J. Cox, A. U. Dogan, H. I. Pass, S. Trusa, M. Hesdorffer, M. Nasu, A. Powers, Z. Rivera, S. Comertplay, M. Tanji, G. Gaudino, H. Yang, and M. Carbone. 2012. Germline BAP1 mutations predispose to malignant mesothelioma. Nature Genetics 43:1022–25. doi:10.1038/ng.912.
   Web of Science ®Google Scholar
• Thomas, A., Y. Chen, T. Yu, A. Gill, and V. Prasad. 2015. Distinctive clinical characteristic of malignant mesothelioma in young patients. Oncotarget 6:16766–73. doi:10.18632/oncotarget.4414.
   PubMed Web of Science ®Google Scholar
• Tomatis, L., S. Cantoni, F. Carnevale, E. Merler, F. Mollo, P. Ricci, S. Silvestri, P. Vineis, and B. Terracini. 2007. The role of asbestos fiber dimensions in the prevention of mesothelioma. International Journal of Occupational and Environmental Health 13:64–69. doi:10.1179/oeh.2007.13.1.64.
   PubMed Web of Science ®Google Scholar
• Tossavinen, A. 2004. Global use of asbestos and the incidence of mesothelioma. International Journal of Occupational and Environmental Health 10:22–25. doi:10.1179/oeh.2004.10.1.22.
   PubMed Web of Science ®Google Scholar
• Toyokuni, S. 2011. Mysterious link between iron overload and CDKN2A/2B. Journal of Clinical Biochemistry and Nutrition 10:48–49.
   Google Scholar
• U.S. Consumer Product Safety Commission. 1977. Ban of consumer patching compounds containing respirable free-form asbestos. 16 CFR Ch. 11 §1304.5 (1-1-04 Ed): 380-383.
   Google Scholar
• Ugoilini, D., M. Neri, J. Ceppi, A. Cesario, I. Dianzani, R. Filiberti, F. Gemignani, S. Landi, C. Magnani, L. Mutti, R. Puntoni, and S. Bonassi. 2008. Genetic susceptibility to malignant mesothelioma and exposure to asbestos: The influence of the familial factor. Mutation Research 658:162–71. doi:10.1016/j.mrrev.2007.08.001.
   PubMed Web of Science ®Google Scholar
• Wagner, J. C., C. A. Sleggs, and P. Marchard. 1960. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. British Journal of Industrial Medicine 17:260–71.
   PubMedGoogle Scholar
• Wang, X., S. Lin, I. Yu, H. Qiu, Y. Lan, and E. Yano. 2013. Case-specific mortality in a Chinese chrysotile textile worker cohort. Cancer Science 104:245–48. doi:10.1111/cas.12060.
   PubMed Web of Science ®Google Scholar
• Wolff, H., T. Vehmas, P. Oksa, J. Rantanen, and H. Vainio. 2015. Consensus report: Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: Recommendations. Scandinavian Journal of Work, Environment & Health 41:5–15. doi:10.5271/sjweh.3462.
   PubMed Web of Science ®Google Scholar
• Wylie, A. G., and P. A. Candela. 2015. Methodologies for determining the sources, characteristics, distribution, and abundance of asbestiform and non-asbestiform amphibole and serpentine in ambient air and water. Journal of Toxicology and Environmental Health, Part B 18:1–42. doi:10.1080/10937404.2014.997945.
   PubMed Web of Science ®Google Scholar
• Yang, H., J. R. Testa, and M. Carbone. 2008. Mesothelioma epidemiology, carcinogenesis and pathogenesis. Current Treatment Options in Oncology 9:147–57. doi:10.1007/s11864-008-0067-z.
   PubMed Web of Science ®Google Scholar